Faculty
Program Director |
|
James O'Donnell, Ph.D.
|
Molecular Psychopharmacology, Molecular mechanisms of action of psychoactive drugs, Behavioral correlates of drug-receptor interactions in the CNS. |
Program Co-Directors |
Albert Berrebi, Ph.D. |
Principles of organization of neuronal microcircuits in the central auditory pathway.
|
| Kevin Larkin, Ph.D. |
Anxiety, Panic, Stress management, Obsessive compulsive disorder.
|
Suresh Madhavan, Ph.D.
|
Health services research and health policy.
|
Preceptors |
| Ariel Agmon, Ph.D. |
Synaptic circuitry and synaptic development in the cerebral cortex.
|
| Stephen Alway, Ph.D. |
Problems in aging heart and skeletal muscle.
|
| Karen Anderson, Ph.D. |
Identifying determinants of choice.
|
| Albert Berrebi, Ph.D. |
Principles of organization of neuronal microcircuits in the central auditory pathway.
|
| Mary Carter, Ph.D. |
Aging and Quality of Life.
|
| Jeffrey Coben, M.D. |
Intimate partner violence, rural-urban differences in injury causation, prescription drug abuse, and adverse medical events.
|
| Lesley Cottrell, Ph.D. |
Parenting processes, adolescent risk behavior, environmental exposures and child development, childhood obesity.
|
| Kevin Daly, Ph.D. |
How olfactory (odor) signals are processed in the brain.
|
| Richard Dey, Ph.D. |
Neuroanatomical organization and embryological development of airway innervation, examining interconnections between airway neurons and airway structures (smooth muscle, blood vessels, glands, epithelium), and on determining neuronal responses to inhaled irritants.
|
| Geri Dino, Ph.D. |
Tobacco Prevention.
|
| Mitchell Finkel, M.D. |
Stress & Heart Disease; Cardiac Signaling, Myocytes, HIV & Heart Disease, Cardiac Failure.
|
| Amy Fiske, Ph.D. |
The etiology of depression and suicidal behavior in late life and the implications for prevention.
|
| Jefferson Frisbee, Ph.D. |
Alterations to microvascular structure and function during metabolic syndrome development.
|
| R. Turner Goins, Ph.D. |
Disability and chronic disease among older adults with a focus on older American Indians.
|
| Robert Goodman, Ph.D. |
The neural mechanisms controlling episodic secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus during the normal ovarian cycle and the structural and functional changes in the hypothalamus responsible for the reversible suppression of GnRH secretion that occurs prior to puberty and annually in seasonal breeders.
|
| Carole Harris, Ph.D. |
Cardiovascular disease, obesity, childhood anxiety disorders, and measurement of outcomes in chronic disease.
|
| Marc Haut, Ph.D. |
The study of human memory, episodic and working memory. Structural (MRI Volumetrics and Diffusion Tensor Imaging) and functional neuroimaging (PET activation and fMRI) are used to study both normal and clinical populations with a particular focus on the effects of age and of toxins on human memory, brain structure, and function.
|
| Kimberly Horn, Ph.D. |
Alcohol, tobacco and other drug intervention studies and evaluation research.
|
| Jason Huber, Ph.D. |
Two facets of BBB research: improving drug delivery to the CNS and characterizing the functional and structural integrity of the BBB in health and disease.
|
| Dina Jones, Ph.D. |
Physical activity, knee osteoarthritis, total hip and knee arthroplasty, rehabilitation interventions in individuals with rheumatic diseases, epidemiology, and fibromyalgia.
|
| George Kelley, Ph.D. |
Use of the meta-analytic approach for examining the effects of physical activity on health-related disease
|
| Kimberly Kelly Ph.D. |
Cancer risk perception, cancer communication, cancer screening, family history, genetic counseling & behavioral medicine.
|
| Sarah Knox, Ph.D. |
Psychosocial factors and gene expression from a systems biology perspective.
|
| Elizabeth Kyonka, Ph.D. |
Behavioral plasticity in interval timing and choice.
|
| Kevin Larkin, Ph.D. |
Applied Psychophysiology, Clinical Health Psychology & Cardiovascular Behavioral Medicine.
|
| Kennon Lattal, Ph.D. |
Analysis of behavior and their applications to both humans and pets.
|
| James Lewis, Ph.D. |
The functions of human brain regions responsible for our ability to recognize everyday natural sounds and our ability to localize sound in three-dimensional space.
|
| Peter Mathers, Ph.D. |
The molecular genetics of two developmental sensory systems: the eye and the ear.
|
| Rae Matsumoto, Ph.D. |
The effects of drugs on the brain.
|
| Daniel W. McNeil, Ph.D. |
Pain and anxiety and their interaction. Health Psychology, particularly including Behavioral Dentistry. Cultural factors in Health.
|
| H. Montgomery-Downs, Ph.D. |
Sleep and Sleep Disorders
|
| Tracy Morris, Ph.D. |
The area of developmental psychopathology, with a special interest in social anxiety disorder.
|
| James O'Donnell, Ph.D. |
Molecular Psychopharmacology, Molecular mechanisms of action of psychoactive drugs, Behavioral correlates of drug-receptor interactions in the CNS.
|
| Giovanni Piedimonte, Ph.D. |
Airway disease with a particular focus on asthma, specifically early life viral infections and their effect on long-term pediatric pulmonary disease.
|
| Miranda Reed, Ph.D. |
Alzheimer’s Disease and the effects of aging and metabolic conditions on pathology.
|
| Ian Rockett, Ph.D. |
The epidemiology of injury and substance.
|
| Charles Rosen, M.D., Ph.D. |
New combinations of drugs to improve the outcome of patients who have had a stroke.
|
| Usha Sambamoorthi, Ph.D. |
|
| Bernard Schreurs, Ph.D. |
Learning and memory, synaptic plasticity, and functional imaging.
|
| Claire St. Peter Pipkin, Ph.D. |
Assessment & treatment of problem behavior (including re-emergence following treatment), autism and developmental disabilities, procedural/treatment fidelity, reinforcement history effects.
|
| Cindy Tworek, Ph.D. |
Health behavior, health policy, tobacco control, and health outcomes research including adolescent health, community intervention, and substance abuse prevention; in addition to other aspects of health services research related to policy as it affects utilization, access to care, and health outcomes.
|
| Han-Ting Zhang, M.D., Ph.D. |
Signal transduction involved in neurodegenerative and neuropsychiatric disorders.
|
|
 |
